BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 30748020)

  • 21. Apigenin, a modulator of PPARγ, attenuates HFD-induced NAFLD by regulating hepatocyte lipid metabolism and oxidative stress via Nrf2 activation.
    Feng X; Yu W; Li X; Zhou F; Zhang W; Shen Q; Li J; Zhang C; Shen P
    Biochem Pharmacol; 2017 Jul; 136():136-149. PubMed ID: 28414138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rosiglitazone Requires Hepatocyte PPARγ Expression to Promote Steatosis in Male Mice With Diet-Induced Obesity.
    Lee SM; Muratalla J; Diaz-Ruiz A; Remon-Ruiz P; McCann M; Liew CW; Kineman RD; Cordoba-Chacon J
    Endocrinology; 2021 Nov; 162(11):. PubMed ID: 34417811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatocyte-specific Ptpn6 deletion promotes hepatic lipid accretion, but reduces NAFLD in diet-induced obesity: potential role of PPARγ.
    Xu E; Forest MP; Schwab M; Avramoglu RK; St-Amand E; Caron AZ; Bellmann K; Shum M; Voisin G; Paquet M; Montoudis A; Lévy E; Siminovitch KA; Neel BG; Beauchemin N; Marette A
    Hepatology; 2014 May; 59(5):1803-15. PubMed ID: 24327268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Astaxanthin reduces hepatic lipid accumulations in high-fat-fed C57BL/6J mice via activation of peroxisome proliferator-activated receptor (PPAR) alpha and inhibition of PPAR gamma and Akt.
    Jia Y; Wu C; Kim J; Kim B; Lee SJ
    J Nutr Biochem; 2016 Feb; 28():9-18. PubMed ID: 26878778
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Histone H3K9 demethylase JMJD2B induces hepatic steatosis through upregulation of PPARγ2.
    Kim JH; Jung DY; Nagappan A; Jung MH
    Sci Rep; 2018 Sep; 8(1):13734. PubMed ID: 30214048
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14-3-3β and γ differentially regulate peroxisome proliferator activated receptor γ2 transactivation and hepatic lipid metabolism.
    Park S; Yoo S; Kim J; An HT; Kang M; Ko J
    Biochim Biophys Acta; 2015 Oct; 1849(10):1237-47. PubMed ID: 26260846
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The novel intracellular protein CREG inhibits hepatic steatosis, obesity, and insulin resistance.
    Zhang QY; Zhao LP; Tian XX; Yan CH; Li Y; Liu YX; Wang PX; Zhang XJ; Han YL
    Hepatology; 2017 Sep; 66(3):834-854. PubMed ID: 28508477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic Peroxisome Proliferator-Activated Receptor Gamma Signaling Contributes to Alcohol-Induced Hepatic Steatosis and Inflammation in Mice.
    Zhang W; Sun Q; Zhong W; Sun X; Zhou Z
    Alcohol Clin Exp Res; 2016 May; 40(5):988-99. PubMed ID: 27062444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nimesulide, a cyclooxygenase-2 selective inhibitor, suppresses obesity-related non-alcoholic fatty liver disease and hepatic insulin resistance through the regulation of peroxisome proliferator-activated receptor γ.
    Tsujimoto S; Kishina M; Koda M; Yamamoto Y; Tanaka K; Harada Y; Yoshida A; Hisatome I
    Int J Mol Med; 2016 Sep; 38(3):721-8. PubMed ID: 27431935
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Crocin ameliorates hepatic steatosis through activation of AMPK signaling in db/db mice.
    Luo L; Fang K; Dan X; Gu M
    Lipids Health Dis; 2019 Jan; 18(1):11. PubMed ID: 30621686
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SARM1 deletion restrains NAFLD induced by high fat diet (HFD) through reducing inflammation, oxidative stress and lipid accumulation.
    Pan ZG; An XS
    Biochem Biophys Res Commun; 2018 Apr; 498(3):416-423. PubMed ID: 29454967
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thioredoxin-interacting protein mediates hepatic lipogenesis and inflammation via PRMT1 and PGC-1α regulation in vitro and in vivo.
    Park MJ; Kim DI; Lim SK; Choi JH; Kim JC; Yoon KC; Lee JB; Lee JH; Han HJ; Choi IP; Kim HC; Park SH
    J Hepatol; 2014 Nov; 61(5):1151-7. PubMed ID: 25003952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transgenic expression of mutant peroxisome proliferator-activated receptor gamma in liver precipitates fasting-induced steatosis but protects against high-fat diet-induced steatosis in mice.
    Tanaka T; Masuzaki H; Ebihara K; Ogawa Y; Yasue S; Yukioka H; Chusho H; Miyanaga F; Miyazawa T; Fujimoto M; Kusakabe T; Kobayashi N; Hayashi T; Hosoda K; Nakao K
    Metabolism; 2005 Nov; 54(11):1490-8. PubMed ID: 16253638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte-specific, PPARγ-regulated mechanisms to promote steatosis in adult mice.
    Wolf Greenstein A; Majumdar N; Yang P; Subbaiah PV; Kineman RD; Cordoba-Chacon J
    J Endocrinol; 2017 Jan; 232(1):107-121. PubMed ID: 27799461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Degradation of PHLPP2 by KCTD17, via a Glucagon-Dependent Pathway, Promotes Hepatic Steatosis.
    Kim K; Ryu D; Dongiovanni P; Ozcan L; Nayak S; Ueberheide B; Valenti L; Auwerx J; Pajvani UB
    Gastroenterology; 2017 Dec; 153(6):1568-1580.e10. PubMed ID: 28859855
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Liver-specific deletion of the signal transducer and activator of transcription 5 gene aggravates fatty liver in response to a high-fat diet in mice.
    Baik M; Nam YS; Piao MY; Kang HJ; Park SJ; Lee JH
    J Nutr Biochem; 2016 Mar; 29():56-63. PubMed ID: 26895665
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state.
    Su H; Li Y; Hu D; Xie L; Ke H; Zheng X; Chen W
    Free Radic Biol Med; 2018 Oct; 126():269-286. PubMed ID: 30142454
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiotrophin-1 eliminates hepatic steatosis in obese mice by mechanisms involving AMPK activation.
    Castaño D; Larequi E; Belza I; Astudillo AM; Martínez-Ansó E; Balsinde J; Argemi J; Aragon T; Moreno-Aliaga MJ; Muntane J; Prieto J; Bustos M
    J Hepatol; 2014 May; 60(5):1017-25. PubMed ID: 24362075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. GDF10 blocks hepatic PPARγ activation to protect against diet-induced liver injury.
    Platko K; Lebeau PF; Byun JH; Poon SV; Day EA; MacDonald ME; Holzapfel N; Mejia-Benitez A; Maclean KN; Krepinsky JC; Austin RC
    Mol Metab; 2019 Sep; 27():62-74. PubMed ID: 31288993
    [TBL] [Abstract][Full Text] [Related]  

  • 40. RORα controls hepatic lipid homeostasis via negative regulation of PPARγ transcriptional network.
    Kim K; Boo K; Yu YS; Oh SK; Kim H; Jeon Y; Bhin J; Hwang D; Kim KI; Lee JS; Im SS; Yoon SG; Kim IY; Seong JK; Lee H; Fang S; Baek SH
    Nat Commun; 2017 Jul; 8(1):162. PubMed ID: 28757615
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.